Evaluation of potentially significant increase of lead in the blood during long-term bed rest and space flight

Physiological Measurement

Volumn 26, Issue 1, 2005, Pages 1-12

  Kondrashov, Vladislav ^a   Rothenberg, Stephen J ^a,b   Chettle, David ^c   Zerwekh, Joseph ^d  

^a CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^c MCMASTER UNIVERSITY   (Canada)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Bed rest; Blood lead; Bone lead; Bone resoption; In vivo x ray fluorescence analysis; Lead toxicity; Skeletal unloading; Space flight

Indexed keywords

BLOOD; BONE; CLINICAL RESEARCH; FLUORESCENCE; MANNED SPACE FLIGHT; MICROGRAVITY; MICROGRAVITY PROCESSING; UNLOADING;

BED RESTS; BLOOD LEAD; BONE LEAD; BONE RESOPTION; IN VIVO X-RAY FLUORESCENCE ANALYSE; IN-VIVO; LEAD CONCENTRATION; LEAD TOXICITY; SKELETAL UNLOADING; X RAY FLUORESCENCE ANALYSIS;

TOXICITY;

CALCIUM; LEAD;

ARTICLE; BED REST; BLOOD; BONE; CALCULATION; CLINICAL RESEARCH; COMA; LEAD BLOOD LEVEL; LEAD POISONING; MICROGRAVITY; PARALYSIS; PREDICTION; PREGNANCY COMPLICATION; PRIORITY JOURNAL; SPACE FLIGHT; SPINE INJURY; THEORETICAL STUDY; FORECASTING; HUMAN; METABOLISM; NASA DISCIPLINE REGULATORY PHYSIOLOGY; NON-NASA CENTER; THEORETICAL MODEL; VASCULARIZATION;

NASA DISCIPLINE REGULATORY PHYSIOLOGY; NON-NASA CENTER;

BED REST; BONE AND BONES; FORECASTING; HUMANS; LEAD; MODELS, THEORETICAL; SPACE FLIGHT;

EID: 18744367260     PISSN: 09673334     EISSN: 09673334     Source Type: Journal    
DOI: 10.1088/0967-3334/26/1/001     Document Type: Article

References (38)

1. Abrams S A 1999 Using stable isotopes to access mineral absorption and utilization by children Am. J. Clin. Nutr. 70 955-64
2. ATSDR (Agency for Toxic Substances and Disease Registry) 1988 The Nature and Extent of Lead Poisoning in Children in the United States: A Report to Congress (Atlanta, GA: ATSDR)
3. ATSDR (Agency for Toxic Substances and Disease Registry) 1990 Case Studies in Environmental Medicine: Lead Toxicity (Atlanta, GA: ATSDR)
4. Barry P S I 1975 A comparison of concentrations of lead in human tissue Br. J. Ind. Med. 32 119-39
5. Brito J A A, McNeill F E, Chettle D R and Vaillancourt C 2000 Study of the relationships between bone lead levels and its variation with time and the cumulative blood lead index, in a repeated bone lead survey J. Environ. Monit. 2 271-6
6. Brito J A A, McNeill F E, Stronach I, Webber C E, Wells S, Richard N and Chettle D R 2001 Longitudinal changes in bone lead concentration: implications for modelling of human bone lead metabolism J. Environ. Monit. 3 343-51
7. Brito J A A, McNeill F E, Webber C E, Wells S, Richard N, Carvalho M L and Chettle D R 2002 Evaluation of a novel structural model to describe the endogenous release of lead from bone J. Environ. Monit. 4 1-9
8. Calvo M S, Eyre D R and Gundberg C M 1996 Molecular basis and clinical application of biological markers of bone turnover Endocr. Rev. 17 333-68
9. DeSilva P E 1981 Determination of lead in plasma and studies on its relationship to lead in erythrocytes Br. J. Ind. Med. 38 209-17
10. Everson J and Patterson C C 1980 'Ultra-clean' isotope dilution/mass spectrometric analyses for lead in human blood plasma indicate that most reported values are artificially high Clin. Chem. 26 1603-7
11. Fleming D E B, Boulay D, Richard N S, Robin J-P, Gordon C L, Webber C E and Chettle D R 1997 Accumulated body burden and endogenous release of lead in employees of a lead smelter Environ. Health Perspect. 105 224-33
12. Fleming D E B, Chettle D R, Webber C E and O'Flaherty E J 1999 The O'Flaherty model of lead kinetics: an evaluation using data from a lead smelter population Toxicol. Appl. Pharmacol. 161 100-9
13. Goldman R H, White R, Kales S N and Hu H 1994 Lead poisoning from mobilization of bone stores during thyroxicossis Am. J. Ind. Med. 25 417-24
14. Gordon C L, Chettle D R and Webber C E 1993 An improved instrument for the in vivo detection of bone lead Br. J. Ind. Med. 50 637-41
15. Hangartner T N 1995 Osteoporosis due to disuse Physical Medicine and Rehabilitation Clinics of North America: Osteoporosis vol 6 ed V Matcovic pp 579-94
16. Hu H and Hernandez-Avila M 2002 Lead, bones, women, and pregnancy - the poison within? Am. J. Epideniol. 156 1088-91
17. International Commission on Radiological Protection (ICRP) 1975 Report of the Task Group on Reference Man ICRP Publication 23 (Oxford: Pergamon)
18. Kiselev S L 2003 Private communication
19. Kondrashov V S and Rothenberg S J 2001 How to calculate lead concentration and concentration uncertainty in XRF in vivo bone lead analysis Appl. Radiat. Isot. 55 17-21
20. Landrigan P J 1989 Toxicity of lead at low dose Br. J. Ind. Med. 46 593-6
21. Landrigan P J 1994 Lead Textbook of Clinical Occupational and Environmental Medicine 3rd edn, ed L Rosenstock and M R Cullen (St Louis, MO: Mosby-Year Book) pp 745-54
22. LeBlanc A D, Schneider V, Shackelford L, West S, Oganov V, Bakulin A and Veronin L 1996 Bone mineral and lean tissue loss after long duration space flight J. Bone Miner. Res. 11 S323
23. Legget R W 1993 An age-specific kinetic model of lead metabolism in humans Environ. Health Perspect. 101 598-616
24. Markowitz M E and Weinberger H L 1990 Immobilization-related lead toxicity in previously lead-poisoned children Pediatrics 86 455-7
25. McQuirter J L, Rothenberg S J, Dinkins G A, Norris K C, Kondrashov V S, Manalo M A and Todd A C 2003 Elevated blood lead resulting from maxillofacial gunshot injuries with lead ingestion J. Oral Maxillofacial Surg. 61 593-603
26. Nie H, Chettle D R, Stronach I, Arnold M, Huang S, McNeill F and O'Meara J 2004 A study of MDL improvement for the in vivo measurement of lead in bone Nucl. Instrum. Methods B 213 579-83
27. O'Flaherty E J 1993 Physiologically based models for bone-seeking elements. Kinetics of lead disposition in humans Toxicol. Appl. Pharmacol. 118 16-29
28. O'Flaherty E J 2000 Modeling normal aging bone loss, with consideration of bone loss in osteoporosis Toxicol. Sci. 55 171-88
29. Rabinowitz M B, Wetherill G W and Kopple J D 1976 Kinetic analysis of lead metabolism in healthy humans J. Clin. Invest. 58 260-70
30. Rothenberg S J, Kondrashov V S, Manton V I, Todd A C and Khan F 2001 Seasonal variation in bone lead contribution to blood lead level Environ. Res. A 85 191-4
31. Roy M M, Gordon C L, Beaumont L F, Chettle D R and Webber C E 1997 Further experience with bone lead content measurements in residents of Southern Ontario Appl. Radiat. Isot. 48 391-6
32. Shannon M, Lindy H, Anast C and Graef J 1988 Recurrent lead poisoning in child with immobilization osteoporosis Vet. Hum. Toxicol. 30 586-8
33. Silbergeld E K 1991 Lead in bone: implications for toxicity during pregnancy and lactation Environ. Health Perspect. 91 63-70
34. Simons T J B 1988 Lead-calcium interactions and lead toxicity Handbook of Experimental Pharmacology vol 83 (Berlin: Springer) pp 509-25
35. Smith S M, Wastney M E, Morukov B V, Larina I M, Nyquist L E, Abrams S A, Taran E N, Shih C Y, Nillen J L, Davis-Street J E, Rice B L and Lane H W 1999 Calcium metabolism before, during, and after a 3-month spaceflight: kinetics and biochemical changes Am. J. Physiol. 277 R1-10
36. Udden M M, Driscoll T B, Pickett M H, Leach-Huntoon C S and Alfrey C P 1995 Decreased production of red blood cells in human subjects exposed to microgravity J Lab Clin. Med. 1254 442-9
37. US EPA (US Environmental Protection Agency) 1997 Integrated Risk Information System (IRIS) Risk Information for Lead and Compounds (Inorganic) (Washington, DC: National Center for Environmental Assessment)
38. US EPA (US Environmental Protection Agency) 2002 National Primary Drinking Water Regulations: Control of Lead and Copper Fed. Reg. 56: 26548